• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    More On PLMO

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Pulmo BioTech, Inc. (PLMO)

    -Other OTC
    0.00 0.00(0.00%) Apr 10
    Add to Portfolio
    Prev Close:0.00
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:N/A
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for PLMO at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pulmo BioTech, Inc., through its subsidiary, PulmoScience, Inc., develops a non-invasive molecular imaging technique for the diagnosis of pulmonary embolism, pulmonary hypertension, and lung inflammatory diseases under the trade name PulmoBind. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback